Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-23
2011-08-23
Shiao, Rei-tsang (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S378000, C514S506000, C560S008000
Reexamination Certificate
active
08003686
ABSTRACT:
The present invention relates to the use of acyl derivatives of curcumin, desmethoxy curcumin and bisdesmethoxy curcumin and of curcuminisoxazolide as components of animal feed or feed additives for the improvement of animal performance and the new acyl derivatives per se as well as the corresponding animal feed or feed additives containing them.
REFERENCES:
patent: WO 2004/031122 (2004-04-01), None
patent: WO 2004/031122 (2004-04-01), None
Devi et al., Current Science, 2004, 87(10): 1324-1325.
Selvam et al. , Bioorganic & Medicinal Chemistry Letters, 2005, 15:1793-1797.
Sui et al., 1995, CAS: 122:23248.
Qiao et al. , Journal Lab. Clin. Med., 1997, 130(6):576 (Abstract only).
Patent Abstracts of Japan, vol. 1998, No. 10, Aug. 31, 1998 & JP 10 114647 A, May 6, 1998.
Pedersen et al, “Synthesis of Naturally Occurring Curcuminoids and Related Compounds”, Liebigs Annalen Der Chemie, Verlag Chemie, GMBH, Weinheim, DE, 1985, pp. 1557-1569.
Milobedzka et al, “Zur Kenntnis des Curcumins”, Ber. Deutsch. Chem. Gessellschaft, vol. 43, 1910, pp. 2163-2170.
Ireson et al, “Characterization of Metabolites of the Chemopreventive Agent Curcumin in Human and Rate Hepatocytes and in the Rat in Vivo, and Evaluation of Their Ability to Inhibit Phorbol Ester-induced Prostaglandin E2 Production”, Cancer Research, American Association for Cancer Research, Baltimore, MD, US, vol. 61, No. 3, Feb. 1, 2001.
Selvam et al, “Desig, synthesis, biological evaluation and molecular docking of curcumin analogues as antioxidant, cyclooxygenase inhibitory and anti-inflammatory agents”, Bioorganic & Medicinal Chemistry Letters, Oxford, GB, vol. 15, No. 7, Apr. 1, 2005, pp. 1793-1797.
Sui et al, “Inhibition of the HIV-1 and HIV-2 Proteases by Curcumin and Curcumin Boron Complexes”, Bioorganic & Medicinal Chemistry, vol. 1, No. 6, 1993, pp. 415-422.
Database CAPLUS Chemical Abstracts Service, Columbus, Ohio, US; XP002397849 & h. Qizhi et al, “High-performance liquid chromatography of complex derived from boron and curcumin and its application”, Fenxi Huaxue, vol. 23, No. 3, 1995, pp. 314-316.
& v. Lampe et al, “Synthesis of p,p′-dihydroxydicinnamylmethane” Berichte Der Deutschen Chemischen Gesselschaft, vol. 51, 1918, pp. 1355-1360.
International Search Report mailed Sep. 9, 2006 in PCT/EP2006/003603.
Written Opinioni mailed Sep. 9, 2006 in PCT/EP2006/003603.
Neupert Werner
Seon Aurelia
Simoes-Nunes Carlos
Wehrli Christof
DSM IP Assets B.V.
Nixon & Vanderhye P.C.
Shiao Rei-tsang
LandOfFree
Aryl derivatives of curcumin, demethoxycurcumin,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl derivatives of curcumin, demethoxycurcumin,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl derivatives of curcumin, demethoxycurcumin,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2740137